相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group
Suman Malempati et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing program
E. Anders Kolb et al.
PEDIATRIC BLOOD & CANCER (2012)
Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin-like Growth Factor I Receptor Monoclonal Antibody
Dong Hoon Shin et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab(CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
David Olmos et al.
LANCET ONCOLOGY (2010)
Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Yonglei Shang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
IMC-A12, a human IgG, monoclonal antibody to the insulin-like growth factor I receptor
Eric K. Rowinsky et al.
CLINICAL CANCER RESEARCH (2007)
Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis
Kai-Da Wu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Insulin-like growth factor-I receptor signaling blockade combined with radiation
Gregory W. Allen et al.
CANCER RESEARCH (2007)
Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo
Barbara Tanno et al.
CLINICAL CANCER RESEARCH (2006)
Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors
Jennifer D. Wu et al.
CLINICAL CANCER RESEARCH (2006)
Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of ana plastic thyroid carcinoma
Zhuoying Wang et al.
CLINICAL CANCER RESEARCH (2006)
Down-regulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: Implications for anti-insulin-like growth factor therapy in breast cancer
D Sachdev et al.
CANCER RESEARCH (2006)
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors
K Scotlandi et al.
CANCER RESEARCH (2005)
On the estimation of the binomial probability in multistage clinical trials
SH Jung et al.
STATISTICS IN MEDICINE (2004)
IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma
EG MacEwen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
The insulin-like growth factor system and cancer
D LeRoith et al.
CANCER LETTERS (2003)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
